Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Latest News
    • Triple therapy lowers...

    Triple therapy lowers exacerbation rate in COPD : BMJ

    Written by Vinay Singh singh Published On 2018-11-18T19:28:54+05:30  |  Updated On 18 Nov 2018 7:28 PM IST
    Triple therapy lowers exacerbation rate in COPD : BMJ

    A new study published in the journal The BMJ reports that the use of triple therapy resulted in a lower rate of moderate or severe exacerbations of COPD, better lung function, and better health-related quality of life than dual therapy or monotherapy in patients with advanced COPD.


    Yayuan Zheng and associates conducted a study to compare the rate of moderate to severe exacerbations between triple therapy and dual therapy or monotherapy in patients with chronic obstructive pulmonary disease (COPD).


    Read Also: FDA approves once-daily, inhalation solution for COPD


    The meta-analysis included 21 trials (19 publications). Triple therapy consisted of a long-acting muscarinic antagonist (LAMA), long-acting β agonist (LABA), and inhaled corticosteroid (ICS).


    The key study findings included are:




    • Triple therapy was associated with a significantly reduced rate of moderate or severe exacerbations compared with LAMA monotherapy, LAMA, and LABA (0.78, 0.70 to 0.88), and ICS and LABA (0.77, 0.66 to 0.91).

    • Trough forced expiratory volume in 1 second (FEV1) and quality of life was favorable with triple therapy.

    • The overall safety profile of triple therapy is reassuring, but pneumonia was significantly higher with triple therapy than with dual therapy of LAMA and LABA (relative risk 1.53).


    "In this meta-analysis of 21 trials, we found that triple therapy (of LABA, LAMA, and inhaled corticosteroids combined) was associated with a significantly larger reduction in the rate of moderate or severe COPD exacerbations than dual therapy (of LAMA and LABA, or inhaled corticosteroids and LABA) or monotherapy (LAMA only). Surrogate outcomes such as spirometry (FEV1) and quality of life (SGRQ score) were favorable, and the overall safety profile of triple therapy is reassuring, but pneumonia was significantly higher with triple therapy than with dual therapy of LAMA and LABA, "write the authors.


    Read Also: Adding theophylline to ICS does not reduce exacerbations in COPD
    Chronic obstructive pulmonary disease (COPD) represents one of the most important public health challenges because of its high prevalence and related disability and mortality. Management of COPD mainly relies on inhaled drugs, including inhaled corticosteroids, long-acting β2 adrenoceptor agonists (LABA), and long-acting muscarinic receptor antagonists (LAMA). Pharmacological management of COPD tends to begin with monotherapy, and step up to dual or triple therapy, as necessary, to control symptoms.


    chronicCOPDcorticosteroiddiseasedrugsdualexacerbationsfunctionLABALAMAlungmanagementmonotherapyobstructivePulmonaryQuality of lifeSymptomstherapytripleYayuan Zheng
    Source : With inputs from BMJ

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Vinay Singh singh
    Vinay Singh singh
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok